April 18, 2024

Pharmaceutical Giant Eli Lilly to Cap Monthly Out-of-Pocket Insulin Costs at $35

Pharmaceutical giant Eli Lilly has announced it is instituting a $35 dollar monthly cap on out-of-pocket insulin expenses. The company announced on Wednesday that it is moving forward with โ€œprice reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs at $35 or

Target market cap now down $10.5 billion in wake of boycott

The American Family Association’s pledge to boycott Target because of its policy to allow men into women’s bathrooms, and vice versa, has reached 1.3 million signers, and Target’s stock (TGT) continues to suffer compared to that of its natural competitors. At the close of trading on Tuesday, the boycott-induced direct decline in Target’s market cap […]

Source: